메뉴바로가기 본문바로가기
  • 메인이미지
  • 메인이미지
  • 메인이미지

Innovative Solutions to
Infectious Diseases

Contributions to Global Public Health through Innovative Recombinant Protein Technology

Learn more 더 보기

About InThera

Innovative Vaccine
Development &
Manufacturing Technology

InThera Inc. aims to develop and deliver the next generation virus-like
particle (VLP)-based prophylactic and therapeutic vaccines
with an improved efficacy and safety profile against emerging/re-emerging
viral infections of global concern.

Learn more 더 보기
about 이미지01
about 이미지02

Technology

High-yield & rapid
production technology

InThera Inc. established a novel E. coli –based VLP production platform which offers
efficient, homologous,stable and highly immunogenic products and significantly
reduces scaling-up time and complexity
The endeavor will heighten the translation opportunity for unmet-need vaccines,
as well as providing alternative means for the delivery of safer and more effective
version of previously licensed vaccines

Learn more 더 보기

Pipeline

InThera next-generation pipeline

  • Pipe line 01 - Norovirus vaccines preventing food poisoning

    Globally ~700 million cases per year (2016) & A vaccine candidate with a great commercial value due to market
    demand in both developing and developed countries
    The absence of a norovirus cell culture system & Unfeasible to develop vaccines with conventional methods
    -> A novel VLP vaccine can create a large market.

    Learn more 더 보기
  • Pipe line 02 - Rotavirus acute gastroenteritis vaccines

    Rotavirus PNP Vaccine
    Business plan for Rota Virus vaccine will be developed in two main market sectors. The first will be GAVI, 
    supporting Low- and Middle-
    Income Countries where Global Excess will be placed. The other sector will be largely populated countries with high
    Rota virus prevalence.

    Learn more 더 보기
  • Pipe line 03 - Mosquito-borne infectious diseases according to climate change

    Outbreaks of emerging and mutant viruses, oversea inflow & the highest potential for pandemic due to climate change
    No spontaneous infection in S. Korea
    Severe symptoms, Emerging in new regions and increased incidence due to climate change, and fast spreading

    Learn more 더 보기